BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12007950)

  • 1. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
    Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
    Sur RK; Donde B; Levin VC; Mannell A
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
    Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
    Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
    Bhatt L; Tirmazy S; Sothi S
    Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.
    Sharma V; Mahantshetty U; Dinshaw KA; Deshpande R; Sharma S
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):310-5. PubMed ID: 11872275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer.
    Skowronek J; Piotrowski T; Zwierzchowski G
    Brachytherapy; 2004; 3(2):87-94. PubMed ID: 15374540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate brachytherapy for superficial cancer of the esophagus.
    Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of multidisciplinary treatment with high dose rate intraluminal brachytherapy on survival in patients with unresectable esophageal cancer.
    Iwasa M; Ohmori Y; Iwasa Y; Yamamoto A; Inoue A; Maeda H; Kume M; Ogoshi S; Nishioka A; Ogawa Y; Yoshida S
    Dig Surg; 1998; 15(3):227-35. PubMed ID: 9845590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
    Okawa T; Dokiya T; Nishio M; Hishikawa Y; Morita K
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):623-8. PubMed ID: 10524414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
    Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors.
    Niemoeller OM; Pöllinger B; Niyazi M; Corradini S; Manapov F; Belka C; Huber RM
    Radiat Oncol; 2013 Jan; 8():8. PubMed ID: 23289530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer.
    Taal BG; Aleman BM; Koning CC; Boot H
    Br J Cancer; 1996 Nov; 74(9):1452-7. PubMed ID: 8912544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA.
    Gaspar LE; Nag S; Herskovic A; Mantravadi R; Speiser B
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):127-32. PubMed ID: 9212013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors.
    Huber RM; Fischer R; Hautmann H; Pöllinger B; Häussinger K; Wendt T
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):533-40. PubMed ID: 9231677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection.
    Steyerberg EW; Homs MY; Stokvis A; Essink-Bot ML; Siersema PD;
    Gastrointest Endosc; 2005 Sep; 62(3):333-40. PubMed ID: 16111947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
    Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
    Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.